No BS RX review

No BS RX publishes an unusually detailed GLP-1 price table, with standard-dose and low-dose programs separated before an intake. Its current standard injection prices are lower than our earlier review: $149 for semaglutide and $225 for tirzepatide on the monthly option. Its biggest strength is the ability to compare actual program terms without first completing a health questionnaire.

The important qualification is that its policy pages distinguish platform, clinical and pharmacy services. A shopper should confirm what the chosen program includes and what happens to each part of the relationship when canceling. This review assesses the company's public program, prices and policies.

How much does No BS RX cost?

The standard monthly options are $149 for injectable semaglutide, $225 for injectable tirzepatide and $174 for oral semaglutide. The pricing table labels these standard programs separately from microdose options, which start at $115. The lower-dose figure should not be substituted for a standard treatment plan.

Longer blocks are also displayed openly. Injectable semaglutide lists $390 for 12 weeks, $790 for 24 weeks and $1,551 for 52 weeks. Standard tirzepatide lists $548, $1,142 and $2,225 for those respective durations. Oral semaglutide lists $497, $987 and $1,893.

A twelve-week purchase is 84 days, not three calendar months. Compare the supply duration and actual amount charged before dividing it into a monthly equivalent. The table's full totals are more useful than an attractive rounded number, particularly when another provider bills by calendar month or every four weeks.

The current site also offers $20 off a first order through an October promotion. That is a temporary discount, separate from the continuing program price. Confirm the selected renewal amount and whether the program renews for the same multi-week term.

What does the service provide?

The published process combines an intake, licensed-provider review and pharmacy fulfillment when prescribed. Each program row identifies 503A pharmacy fulfillment and says there are no dose-based price changes. That supports a predictable bill within a selected program, while leaving dose selection with the clinician.

The how-it-works and FAQ pages describe provider-guided care and access to support. Ask whether follow-up is by messaging or live appointments, who handles clinical questions and how prescription changes are communicated. A flat-price program should still have a clear medical plan if tolerability changes.

The terms name dispensing partners including Red Rock, Health Warehouse, Precision Medicine and Triad Rx. That is a useful disclosure of possible pharmacies, but not proof that all four are involved in your order or that a shared pharmacy establishes shared ownership with another telehealth company.

Before dispensing, obtain the actual pharmacy assignment, formulation, concentration and storage instructions. The program's public quality claims do not replace those order-specific details. Our compounded versus brand-name GLP-1 guide explains why the actual preparation matters more than a familiar active-ingredient name.

How do standard and microdose plans differ?

The table separates standard oral semaglutide, standard injections and lower-dose programs. That makes the comparison clearer, but a lower-priced microdose program should not be assumed to achieve the same results as a higher-dose or approved product studied in trials.

Ask what the clinician is treating, what dose range is included, how response is assessed and what happens if the selected program no longer fits. Moving from a low-dose plan to a standard program can change the product and bill even when a website says no dose-based increases within a plan.

Oral semaglutide is a compounded formulation rather than an FDA-approved branded pill. Its route and evidence should be discussed separately. Someone who dislikes injections should compare the actual oral plan and approved alternatives rather than assume any product with semaglutide in its name is interchangeable.

Is there anything useful for women beyond weight care?

The public GLP-1 offer is general weight management. It does not establish a dedicated menopause practice, PCOS clinic or fertility service. A woman with PCOS should ask who continues to manage symptoms and prescriptions outside the weight-treatment plan. Our GLP-1 and PCOS guide can help frame that distinction.

No BS RX also has a separate sleep program using an at-home diagnostic device and clinical interpretation. The current cash price is $396, with financing available, rather than a $33 monthly medication subscription. Confirm what is included, the number of visits and what happens after the diagnostic result.

That may be a relevant adjacent service for someone concerned about sleep, but it is not proof that adding a GLP-1 treats all sleep symptoms. Our sleep apnea in women and GLP-1 guide explains why assessment and treatment decisions should remain specific to the diagnosis and product.

What happens when you cancel?

The subscription terms describe automatic renewal for successive periods of the same duration unless canceled. Cancellation generally takes effect at the end of the current billing period and does not itself refund amounts already charged. A platform cancellation also does not automatically end every separate clinical relationship.

The refund page distinguishes administrative fees from clinical and medication charges. It provides a narrow initial 48-hour route when clinical services have not started and the intake has not been completed, while other amounts may become non-refundable once services are provided. Ask which policy applies to the actual bundled price before selecting a long block.

State availability is not clearly enumerated in the reviewed pricing table. Confirm your location and medication before relying on the advertised rate. No BS RX is strongest for a shopper who values a complete public ladder and named dispensing partners, provided the selected plan's renewal, clinical support and refund terms are equally clear.